InvestorsHub Logo

kris_kade

02/06/15 6:33 AM

#477 RE: tooka31 #475

Absolutely ! I too have large position and NPV today is $2.75 even without start of P3 ! So a start of P3 and even better under SPA agreement with FDA will add lot more fuel to fire.

Also the odds of buyout this year will
Increase. Civitas was bought out by ACOR at substantial premium when they did not even complete P3.

noretreat

02/06/15 7:08 AM

#478 RE: tooka31 #475

I think 2 bucks this year is very reasonable. If it happens by summer it will mean p3 is off and running...

The risk here is that too much delay will give the inhaler time to resolve the need for premixing